{"id":"https://openalex.org/W2604450134","doi":"https://doi.org/10.1093/neuonc/nox041","title":"How can we develop therapies for glioblastoma more efficiently? Randomized versus single-arm studies","display_name":"How can we develop therapies for glioblastoma more efficiently? Randomized versus single-arm studies","publication_year":2017,"publication_date":"2017-03-28","ids":{"openalex":"https://openalex.org/W2604450134","doi":"https://doi.org/10.1093/neuonc/nox041","mag":"2604450134","pmid":"https://pubmed.ncbi.nlm.nih.gov/28388714","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5464309"},"language":"en","primary_location":{"id":"doi:10.1093/neuonc/nox041","doi":"https://doi.org/10.1093/neuonc/nox041","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/nox041","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/19/4/459/17697225/nox041.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/neuro-oncology/article-pdf/19/4/459/17697225/nox041.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021656597","display_name":"Patrick Yung Wen","orcid":"https://orcid.org/0000-0002-0774-7700","observed_orcids":["https://orcid.org/0000-0002-0774-7700","https://orcid.org/0000-0003-3224-3042","https://orcid.org/0000-0002-2452-0540"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I183519381","display_name":"Capital Medical University","ror":"https://ror.org/013xs5b60","country_code":"CN","type":"education","lineage":["https://openalex.org/I183519381"]},{"id":"https://openalex.org/I4210087691","display_name":"Beijing Tian Tan Hospital","ror":"https://ror.org/003regz62","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210087691"]},{"id":"https://openalex.org/I4210102457","display_name":"Center for Neuro-Oncology","ror":"https://ror.org/00z2tp793","country_code":"US","type":"facility","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210102457","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I51556381","display_name":"University of Virginia","ror":"https://ror.org/0153tk833","country_code":"US","type":"education","lineage":["https://openalex.org/I51556381"]}],"countries":["CN","US"],"is_corresponding":false,"raw_author_name":"Patrick Y. Wen","raw_affiliation_strings":["Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center,  Boston, MA, USA","Harvard Medical School, Boston, MA, USA","Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center (P.Y.W.)","Department of Neurology, University of Virginia, Charlottesville, Virginia (D.S.)","Department of Neurosurgery, Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University (T.J.)","Harvard Medical School (P.Y.W.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center,  Boston, MA, USA","institution_ids":["https://openalex.org/I4210102457","https://openalex.org/I4210161994"]},{"raw_affiliation_string":"Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center (P.Y.W.)","institution_ids":["https://openalex.org/I4210102457","https://openalex.org/I4210161994"]},{"raw_affiliation_string":"Department of Neurology, University of Virginia, Charlottesville, Virginia (D.S.)","institution_ids":["https://openalex.org/I51556381"]},{"raw_affiliation_string":"Department of Neurosurgery, Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University (T.J.)","institution_ids":["https://openalex.org/I183519381","https://openalex.org/I4210087691"]},{"raw_affiliation_string":"Harvard Medical School (P.Y.W.)","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070697945","display_name":"Tao Jiang","orcid":"https://orcid.org/0000-0002-7008-6351","observed_orcids":["https://orcid.org/0000-0002-7008-6351","https://orcid.org/0009-0004-6284-9162"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I183519381","display_name":"Capital Medical University","ror":"https://ror.org/013xs5b60","country_code":"CN","type":"education","lineage":["https://openalex.org/I183519381"]},{"id":"https://openalex.org/I4210087691","display_name":"Beijing Tian Tan Hospital","ror":"https://ror.org/003regz62","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210087691"]},{"id":"https://openalex.org/I4210102457","display_name":"Center for Neuro-Oncology","ror":"https://ror.org/00z2tp793","country_code":"US","type":"facility","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210102457","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210113914","display_name":"Beijing Institute of Neurosurgery","ror":"https://ror.org/01xbd6g65","country_code":"CN","type":"facility","lineage":["https://openalex.org/I4210113914"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I51556381","display_name":"University of Virginia","ror":"https://ror.org/0153tk833","country_code":"US","type":"education","lineage":["https://openalex.org/I51556381"]}],"countries":["CN","US"],"is_corresponding":false,"raw_author_name":"Tao Jiang","raw_affiliation_strings":["Department of Neurosurgery, Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing, China","Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center (P.Y.W.)","Department of Neurology, University of Virginia, Charlottesville, Virginia (D.S.)","Department of Neurosurgery, Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University (T.J.)","Harvard Medical School (P.Y.W.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurosurgery, Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing, China","institution_ids":["https://openalex.org/I183519381","https://openalex.org/I4210087691","https://openalex.org/I4210113914"]},{"raw_affiliation_string":"Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center (P.Y.W.)","institution_ids":["https://openalex.org/I4210102457","https://openalex.org/I4210161994"]},{"raw_affiliation_string":"Department of Neurology, University of Virginia, Charlottesville, Virginia (D.S.)","institution_ids":["https://openalex.org/I51556381"]},{"raw_affiliation_string":"Department of Neurosurgery, Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University (T.J.)","institution_ids":["https://openalex.org/I183519381","https://openalex.org/I4210087691"]},{"raw_affiliation_string":"Harvard Medical School (P.Y.W.)","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023905352","display_name":"David Schiff","orcid":"https://orcid.org/0000-0002-1896-2502","observed_orcids":["https://orcid.org/0000-0002-1896-2502","https://orcid.org/0000-0003-1561-9220"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I183519381","display_name":"Capital Medical University","ror":"https://ror.org/013xs5b60","country_code":"CN","type":"education","lineage":["https://openalex.org/I183519381"]},{"id":"https://openalex.org/I4210087691","display_name":"Beijing Tian Tan Hospital","ror":"https://ror.org/003regz62","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210087691"]},{"id":"https://openalex.org/I4210102457","display_name":"Center for Neuro-Oncology","ror":"https://ror.org/00z2tp793","country_code":"US","type":"facility","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210102457","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I51556381","display_name":"University of Virginia","ror":"https://ror.org/0153tk833","country_code":"US","type":"education","lineage":["https://openalex.org/I51556381"]}],"countries":["CN","US"],"is_corresponding":false,"raw_author_name":"David Schiff","raw_affiliation_strings":["Department of Neurology, University of Virginia, Charlottesville, Virginia, USA","Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center (P.Y.W.)","Department of Neurology, University of Virginia, Charlottesville, Virginia (D.S.)","Department of Neurosurgery, Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University (T.J.)","Harvard Medical School (P.Y.W.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, University of Virginia, Charlottesville, Virginia, USA","institution_ids":["https://openalex.org/I51556381"]},{"raw_affiliation_string":"Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center (P.Y.W.)","institution_ids":["https://openalex.org/I4210102457","https://openalex.org/I4210161994"]},{"raw_affiliation_string":"Department of Neurology, University of Virginia, Charlottesville, Virginia (D.S.)","institution_ids":["https://openalex.org/I51556381"]},{"raw_affiliation_string":"Department of Neurosurgery, Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University (T.J.)","institution_ids":["https://openalex.org/I183519381","https://openalex.org/I4210087691"]},{"raw_affiliation_string":"Harvard Medical School (P.Y.W.)","institution_ids":["https://openalex.org/I136199984"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5132,"currency":"USD","value_usd":5132},"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.0370345,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"19","issue":"4","first_page":"459","last_page":"460"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9919999837875366},{"id":"https://openalex.org/keywords/recurrent-glioblastoma","display_name":"recurrent glioblastoma","score":0.6489999890327454},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.7910000085830688},{"id":"https://openalex.org/keywords/treatment-sequencing","display_name":"treatment sequencing","score":0.3479999899864197},{"id":"https://openalex.org/keywords/molecular-heterogeneity","display_name":"molecular heterogeneity","score":0.7039999961853027},{"id":"https://openalex.org/keywords/tumor-resistance","display_name":"tumor resistance","score":0.4009999930858612},{"id":"https://openalex.org/keywords/temozolomide","display_name":"temozolomide","score":0.8460000157356262},{"id":"https://openalex.org/keywords/tumor-treating-fields","display_name":"tumor treating fields","score":0.9200000166893005},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9229999780654907},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.5099999904632568},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.6050000190734863},{"id":"https://openalex.org/keywords/trial-design","display_name":"trial design","score":0.39500001072883606},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.4830000102519989},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.5960000157356262},{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.4819999933242798},{"id":"https://openalex.org/keywords/imatinib","display_name":"imatinib","score":0.925000011920929}],"concepts":[{"id":"https://openalex.org/C2776194525","wikidata":"https://www.wikidata.org/wiki/Q282142","display_name":"Glioblastoma","level":2,"score":0.6970483064651489},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5645812749862671},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5083975195884705},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3655714988708496},{"id":"https://openalex.org/C99508421","wikidata":"https://www.wikidata.org/wiki/Q2678675","display_name":"Physical medicine and rehabilitation","level":1,"score":0.32399410009384155},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2803613841533661},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.14524224400520325}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D003606","descriptor_name":"Dacarbazine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005909","descriptor_name":"Glioblastoma","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1093/neuonc/nox041","doi":"https://doi.org/10.1093/neuonc/nox041","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/nox041","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/19/4/459/17697225/nox041.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5464309","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5464309","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro Oncol","raw_type":"Text"},{"id":"pmid:28388714","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28388714","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-oncology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1093/neuonc/nox041","doi":"https://doi.org/10.1093/neuonc/nox041","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/nox041","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/19/4/459/17697225/nox041.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9476000070571899,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2604450134.pdf","grobid_xml":"https://content.openalex.org/works/W2604450134.grobid-xml"},"referenced_works_count":12,"referenced_works":["https://openalex.org/W1968747503","https://openalex.org/W2008259119","https://openalex.org/W2040458067","https://openalex.org/W2101922439","https://openalex.org/W2123808042","https://openalex.org/W2160959204","https://openalex.org/W2162643152","https://openalex.org/W2205491921","https://openalex.org/W2336852147","https://openalex.org/W2558690325","https://openalex.org/W2604818452","https://openalex.org/W2749747068"],"related_works":["https://openalex.org/W4295758394","https://openalex.org/W2017917846","https://openalex.org/W2185540316","https://openalex.org/W2728315087","https://openalex.org/W7126348658","https://openalex.org/W2115496571","https://openalex.org/W2912972195","https://openalex.org/W4313557962","https://openalex.org/W2726865265","https://openalex.org/W1987668448"],"abstract_inverted_index":{"See":[0],"article":[1],"in":[2,15,69,78,92,107,114,146,170,263,300,323,327,357,399,414,454,471,483,485,515,523,551,578,634,652,796,843,916,1015],"this":[3,121,639,807],"issue":[4,640],"by":[5,379,582,600,923,929],"Grossman":[6,643],"et":[7,644],"al.":[8,645],"pp.":[9],"469\u2013474.":[10],"Despite":[11],"extensive":[12],"efforts,":[13],"progress":[14],"finding":[16],"more":[17,225,239,291,519,825,839,938],"effective":[18,132,420,437,1063],"therapies":[19,133,157,200,222,413,680,718,833,997],"for":[20,51,62,90,134,201,312,348,373,394,573,589,659,681,737,749,755,774,879,958,998,1055,1065],"patients":[21,361,444,458,587,703,711,750,933,1017],"with":[22,116,204,362,507,546,716,751,757,831,962,985,1018,1022,1037],"glioblastomas":[23,52,63,215,402,517,984],"has":[24,64,123],"been":[25,40],"disappointing.":[26],"With":[27],"the":[28,44,66,93,108,128,171,190,194,232,235,260,267,272,306,345,369,380,415,474,478,481,500,563,583,601,628,649,653,663,699,707,885,913,945,993,1003,1029,1050],"modest":[29],"exceptions":[30],"of":[31,59,130,139,184,274,280,286,308,318,340,344,360,371,427,446,449,462,468,480,538,543,586,632,641,648,655,665,673,693,701,709,783,787,841,856,888,895,941,953,995,1052],"temozolomide,":[32],"bevacizumab,":[33],"and":[34,48,81,141,149,168,217,228,266,334,388,491,505,510,534,549,599,630,686,704,706,770,803,811,827,848,868,908,928,934,967,982,1032,1057],"tumor-treating":[35],"fields":[36],"(TTF)":[37],"there":[38,208,404,432,622,732],"have":[39,255,423],"few":[41],"advances":[42],"over":[43],"past":[45],"two":[46],"decades,":[47],"median":[49],"survival":[50,178,338],"remains":[53],"only":[54,256,358,729],"14\u201318":[55],"months.1":[56],"The":[57,576,671,691,781],"development":[58],"novel":[60,199,412,452,544,901,996,1045,1053],"agents":[61,100,276,281,421,438,453,494,545,937,1040,1054,1064],"followed":[65],"standard":[67,117,156,385,717,832,859],"paradigm":[68],"oncology":[70],"where":[71,418],"a":[72,328,335,352,363,407,424,460,527,535,624,852,854,893,925],"new":[73],"therapy":[74,322,387,509,548],"is":[75,87,209,238,298,623,676,698,740,809],"first":[76,486,552],"evaluated":[77],"recurrent":[79,147,242,264,374,401,472,524,983],"disease,":[80,525],"if":[82,731,816,873],"it":[83,86],"shows":[84],"activity":[85,103,470],"then":[88],"advanced":[89,206,288],"evaluation":[91,570],"first-line":[94,172,416],"setting.":[95],"This":[96,284,739],"approach":[97,122,808],"ensures":[98],"that":[99,213,439,603,719,806],"demonstrate":[101,160],"single-agent":[102,469],"before":[104],"being":[105,282,290],"used":[106,814,878],"adjuvant":[109],"setting,":[110],"either":[111],"alone":[112],"or":[113,277,761,1041],"combination":[115],"therapies.":[118],"While":[119],"reasonable,":[120],"unfortunately":[124],"not":[125,779],"led":[126],"to":[127,159,181,197,220,245,259,293,443,531,566,595,614,617,626,677,687,792,837,899,912,991,1034,1061],"identification":[129],"any":[131],"glioblastomas.":[135,202],"In":[136,163,638],"fact,":[137],"studies":[138,151,542,667,675,727,756,822,904,915],"temozolomide":[140,167,389,550],"TTF":[142,169],"showed":[143,174],"minimal":[144],"responses":[145],"glioblastomas,":[148],"randomized":[150,669,860,889,946,1046],"comparing":[152],"these":[153,397,493,620,674,1044],"treatments":[154],"against":[155],"failed":[158],"significant":[161,177,870],"benefit.":[162],"contrast,":[164],"trials":[165,514,522,593,633,658,697,791,799,863,920,943],"evaluating":[166,411,978],"setting":[173,417],"modest,":[175],"but":[176,834],"benefit,":[179],"leading":[180],"regulatory":[182],"approval":[183],"both":[185,979],"therapies.1,2":[186],"These":[187,919],"results":[188,326],"raise":[189],"important":[191,463,744],"question":[192],"regarding":[193],"optimal":[195,261],"time":[196,234,530,556],"evaluate":[198],"As":[203],"other":[205,302,597],"cancers,":[207,303],"increasing":[210,268,785],"data":[211,476,736,748],"suggesting":[212],"as":[214,305,321,608,746,766],"evolve":[216],"develop":[218],"resistance":[219],"initial":[221],"they":[223,849],"are":[224,518,554,580,610,720,728,733,777,835,850,864,877,897,1026],"molecularly":[226,287],"complex":[227,520],"heterogeneous,3":[229],"while":[230],"at":[231,252,817],"same":[233,346],"immune":[236,382],"system":[237,383],"suppressed,":[240],"making":[241],"tumors":[243],"harder":[244],"treat.":[246],"For":[247,1006],"targeted":[248,758,1038],"agents,":[249,760],"tumor":[250],"genotype":[251],"diagnosis":[253],"may":[254,376,422],"limited":[257,378,584],"relevance":[258],"targets":[262],"tumors,":[265],"molecular":[269,753,759,1039],"heterogeneity":[270],"decreases":[271],"likelihood":[273],"single":[275],"even":[278],"combinations":[279],"effective.":[283,722],"scenario":[285],"cancer":[289],"difficult":[292],"treat":[294],"than":[295,521],"early-stage":[296],"disease":[297,375,473],"found":[299],"many":[301,596],"such":[304,607,765,942],"use":[307,343,479,664,773,855],"imatinib":[309],"mesylate":[310,320],"(Gleevec)":[311],"chronic":[313],"myelogenous":[314],"leukemia":[315],"(CML).":[316],"Use":[317],"imatinb":[319],"chronic-phase":[324],"CML":[325,350],"49\u201388%":[329],"complete":[330,353],"cytologic":[331,354],"response":[332,355],"rate":[333,356],"5-year":[336,366],"progression-free":[337],"(PFS)":[339],"83%\u201394%,4":[341],"whereas":[342],"agent":[347,482],"accelerated":[349],"produces":[351],"21%":[359],"much":[364],"reduced":[365],"PFS.":[367],"Similarly,":[368],"effectiveness":[370],"immunotherapies":[372],"be":[377,406,435,441,489,813,838],"suppressed":[381],"after":[384],"radiation":[386,508,547],"chemotherapy,5":[390],"reducing":[391],"their":[392,447],"chances":[393],"success.":[395],"Given":[396,619],"challenges":[398,577,621,651],"treating":[400],"perhaps":[403],"should":[405,812],"greater":[408],"emphasis":[409],"on":[410,884],"moderately":[419],"better":[425,853],"chance":[426],"improving":[428],"patient":[429],"outcomes.":[430],"Hopefully,":[431,1043],"will":[433,440,1048],"eventually":[434],"truly":[436],"beneficial":[442],"regardless":[445],"stage":[448],"disease.":[450],"Evaluating":[451],"newly":[455,635,660,959,980,999,1019],"diagnosed":[456,636,661,960,981,1000,1020],"glioblastoma":[457,484,579,961,1001,1021,1056],"poses":[459],"number":[461,537,585,786,894],"challenges.":[464],"Without":[465],"clinical":[466,592],"evidence":[467],"preclinical":[475],"supporting":[477],"line":[487,553],"must":[488,495],"robust,":[490],"ideally":[492],"show":[496],"good":[497],"penetration":[498],"across":[499],"blood-brain":[501],"barrier":[502],"when":[503],"relevant,":[504],"synergy":[506],"/or":[511],"temozolomide.":[512],"Clinical":[513],"newly-diagnosed":[516],"requiring":[526,931],"significantly":[528,824],"longer":[529],"determine":[532],"efficacy":[533],"larger":[536],"patients.":[539,1067],"Phase":[540],"I":[541],"particularly":[555],"consuming,":[557],"often":[558],"taking":[559],"1\u20132":[560],"years":[561],"given":[562],"typical":[564],"8-":[565],"10-week":[567],"dose-limiting":[568],"toxicity":[569],"period":[571],"required":[572],"each":[574,880],"cohort.":[575],"compounded":[581],"available":[588],"enrollment":[590],"into":[591,712],"compared":[594],"cancers":[598],"fact":[602],"earlier":[604],"non-survival":[605],"endpoints":[606],"PFS":[609],"relatively":[611,865],"unreliable":[612,810],"due":[613],"issues":[615],"related":[616],"pseudoprogression.6":[618],"need":[625],"improve":[627,883,1058],"design":[629,654,887],"conduct":[631,900],"glioblastoma.":[637],"Neuro-Oncology,":[642],"discuss":[646],"one":[647],"major":[650],"phase":[656,683,695,725,789,797,820,845,861,890,947],"II":[657,696,726,790,821,862,891,948],"glioblastomas:":[662],"single-arm":[666,694,724,788],"versus":[668],"studies.7":[670],"goal":[672],"select":[678],"promising":[679],"definitive":[682],"III":[684,798,846],"testing":[685],"eliminate":[688],"ineffective":[689,936],"treatments.":[690],"attraction":[692],"requirement":[700],"fewer":[702,932],"resources":[705,826],"avoidance":[708],"enrolling":[710],"unattractive":[713],"control":[714,829,875,926],"arms":[715,830,876],"barely":[721],"However,":[723],"valid":[730],"reliable":[734],"historic":[735,747],"comparison.":[738],"becoming":[741],"an":[742,784,975],"increasingly":[743],"limitation":[745],"specific":[752,762,1035],"subsets":[754],"eligibility":[763],"criteria":[764],"gross":[767],"total":[768],"resection":[769],"restricted":[771],"corticosteroid":[772],"immunotherapy":[775],"studies,":[776,892],"generally":[778],"available.":[780],"failure":[782],"accurately":[793],"predict":[794],"outcome":[795],"(cediranib,8":[800],"enzastaurin,9":[801],"cilengitide,10":[802],"rindopepimut11)":[804],"suggests":[805],"sparingly,":[815],"all.":[818],"Randomized":[819],"require":[823],"include":[828,944,1002],"likely":[836],"predictive":[840],"benefit":[842],"subsequent":[844],"trials,":[847],"ultimately":[851],"resources.":[857],"Nonetheless,":[858],"inefficient,":[866],"slow,":[867],"utilize":[869],"resources,":[871],"especially":[872],"separate":[874],"study.":[881],"To":[882],"current":[886],"efforts":[896,990],"underway":[898],"multi-arm":[902],"biomarker-driven":[903],"using":[905,1028],"Bayesian":[906],"designs":[907,1047],"adaptive":[909],"randomization":[910],"similar":[911],"I-Spy":[914],"breast":[917],"cancer.":[918],"achieve":[921],"efficiencies":[922],"sharing":[924],"arm":[927],"potentially":[930],"eliminating":[935],"rapidly.":[939],"Examples":[940],"study":[949],"Individualized":[950],"Screening":[951],"Trial":[952],"Innovative":[954,972],"Glioblastoma":[955],"Therapy":[956],"(INSIGhT)":[957],"unmethylated":[963,1023],"MGMT":[964,1024],"promoter":[965,1025],"(NCT02977780)":[966],"GBM":[968],"AGILE":[969],"(Adaptive":[970],"Global":[971],"Learning":[973],"Environment),":[974],"international":[976],"trial":[977,1014],"registration":[986],"capabilities.":[987],"Other":[988],"innovative":[989],"accelerate":[992,1049],"screening":[994,1051],"National":[1004],"Center":[1005],"Tumor":[1007],"Disease":[1008],"(NCT)":[1009],"Neuro":[1010],"Master":[1011],"Match":[1012],"(N2M2)":[1013],"which":[1016],"genotyped":[1027],"450K":[1030],"array":[1031],"assigned":[1033],"buckets":[1036],"immunotherapies.":[1042],"our":[1059,1066],"ability":[1060],"identify":[1062]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-04-14T00:00:00"}